Not-For-Profit Drug Companies, Smarter Regulations, and Innovative Science Could Identify New Antibiotics and Save Lives New York, NY (October 18, 2004) — The looming threat of bacterial infections resistant to available antibiotics can be averted if industry, regulators, and academics...